The need to prioritize research, policy, and practice to address the overdose epidemic in smaller settings in Canada

Abstract

The majority of research and policy directives targeting opioid use and overdose prevention are based in larger urban settings and not easily adaptable to smaller Canadian settings (i.e., small- to mid-sized cities and rural areas). We identify a variety of research and policy gaps in smaller settings, including limited access to supervised consumption services, safer supply and novel opioid agonist therapy programs, as well as housing-based services and supports. Additionally, we identify the need for novel strategies to improve healthcare access and health outcomes in a more equitable way for people who use drugs, including virtual opioid agonist therapy clinics, episodic overdose prevention services, and housing-based harm reduction programs that are better suited for smaller settings. These programs should be coupled with rigorous evaluation, in order to understand the unique factors that shape overdose risk, opioid use, and service uptake in smaller Canadian settings.

Résumé

La recherche et les politiques d’orientation axées sur l’usage des opioïdes et la prévention des surdoses sont majoritairement basées dans les grandes agglomérations urbaines et ne sont donc pas faciles à adapter aux petites agglomérations du Canada (c.-à-d. aux villes petites et moyennes et aux agglomérations en milieu rural). Nous définissons plusieurs des lacunes de la recherche et des politiques dans les petites agglomérations, dont l’accès limité aux services de consommation supervisée, à l’approvisionnement sûr et aux nouveaux programmes de traitement par agonistes opioïdes, ainsi qu’aux services et aux mesures d’aide fondés sur le logement. Nous définissons aussi le besoin de stratégies novatrices pour améliorer l’accès aux soins de santé et les résultats cliniques de façon plus équitable pour les personnes qui font usage de drogue, notamment le besoin de cliniques virtuelles de traitement par agonistes opioïdes, de services épisodiques de prévention des surdoses et de programmes de réduction des méfaits fondés sur le logement, mieux adaptés aux petites agglomérations. De tels programmes devraient être assortis d’une évaluation rigoureuse pour mettre en lumière les facteurs particuliers qui influencent le risque de surdose, l’usage des opioïdes et le recours aux services dans les petites agglomérations canadiennes.

This is a preview of subscription content, access via your institution.

Data availability

N/A.

Code availability

N/A.

References

  1. Bardwell, G., Scheim, A., Mitra, S., & Kerr, T. (2017). Assessing support for supervised injection services among community stakeholders in London, Canada. The International Journal of Drug Policy, 48, 27–33. https://doi.org/10.1016/j.drugpo.2017.05.009.

    Article  PubMed  Google Scholar 

  2. British Columbia Coroners Service (2021). Illicit drug toxicity deaths in BC: January 1, 2010 - December 31, 2020. British Columbia.

  3. Canadian HIV/AIDS Legal Network. (2006). Nothing about us without us - greater, meaningful involvement of people who use illegal drugs: A public health, ethical, and human rights imperative. Canadian HIV/AIDS Legal Network.

  4. Casorso, J. (2020). Rural and Indigenous Overdose Action Exchange 2019 Report. Urban Matters CCC.

  5. Fairbairn, N., Ross, J., Trew, M., Meador, K., Turnbull, J., MacDonald, S., et al. (2019). Injectable opioid agonist treatment for opioid use disorder: A national clinical guideline. Canadian Medical Association Journal, 191(38), E1049. https://doi.org/10.1503/cmaj.190344.

    Article  PubMed  Google Scholar 

  6. Government of British Columbia, Ministry of Mental Health and Addictions. (2020). The New Lifeguard App Can Help Prevent Overdose Death. https://www.stopoverdose.gov.bc.ca/theweekly/new-lifeguard-app-can-help-prevent-overdose-death. Accessed 26 November 2020.

  7. Kerr, T., Mitra, S., Kennedy, M. C., & McNeil, R. (2017). Supervised injection facilities in Canada: Past, present, and future. Harm Reduction Journal, 14(1), 28. https://doi.org/10.1186/s12954-017-0154-1.

    Article  PubMed  PubMed Central  Google Scholar 

  8. MacKinnon, L., Socías, M. E., & Bardwell, G. (2020). COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings. Journal of Substance Abuse Treatment, 119, 108153. https://doi.org/10.1016/j.jsat.2020.108153.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Mema, S. C., Frosst, G., Bridgeman, J., Drake, H., Dolman, C., Lappalainen, L., et al. (2019). Mobile supervised consumption services in Rural British Columbia: Lessons learned. Harm Reduction Journal, 16(1), 4. https://doi.org/10.1186/s12954-018-0273-3.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Moustaqim-Barrette, A., Papamihali, K., Crabtree, A., Graham, B., Karamouzian, M., & Buxton, J. A. (2019). Correlates of take-home naloxone kit possession among people who use drugs in British Columbia: A cross-sectional analysis. Drug and Alcohol Dependence, 205, 107609. https://doi.org/10.1016/j.drugalcdep.2019.107609.

    CAS  Article  PubMed  Google Scholar 

  11. Parker, J., Jackson, L., Dykeman, M., Gahagan, J., & Karabanow, J. (2012). Access to harm reduction services in Atlantic Canada: Implications for non-urban residents who inject drugs. Health & Place, 18(2), 152–162. https://doi.org/10.1016/j.healthplace.2011.08.016.

    CAS  Article  Google Scholar 

  12. Russell, C., Imtiaz, S., Ali, F., Elton-Marshall, T., & Rehm, J. (2020). ‘Small communities, large oversight’: The impact of recent legislative changes concerning supervised consumption services on small communities in Ontario, Canada. The International Journal of Drug Policy, 82, 102822. https://doi.org/10.1016/j.drugpo.2020.102822.

    Article  PubMed  Google Scholar 

  13. Yang, C., Favaro, J., & Meacham, M. C. (2021). NEXT Harm Reduction: An online, mail-based naloxone distribution and harm-reduction program. American Journal of Public Health, 2021, e1–e5. https://doi.org/10.2105/AJPH.2020.306124.

    Article  Google Scholar 

Download references

Funding

This work was supported by funding from the US National Institutes of Health (R01DA044181). Geoff Bardwell is supported by a Canadian Institutes of Health Research Postdoctoral Fellowship.

Author information

Affiliations

Authors

Contributions

GB wrote the first draft. Both authors made substantial contributions to the work, approved the final version, and agreed to be accountable for all aspects of the manuscript.

Corresponding author

Correspondence to Geoff Bardwell.

Ethics declarations

Ethics approval

N/A.

Consent to participate

N/A.

Consent for publication

N/A.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bardwell, G., Lappalainen, L. The need to prioritize research, policy, and practice to address the overdose epidemic in smaller settings in Canada. Can J Public Health (2021). https://doi.org/10.17269/s41997-021-00504-9

Download citation

Keywords

  • Research
  • Opioid overdose prevention
  • Opioid agonist therapy
  • Supervised consumption services
  • Smaller settings
  • Rural health

Mots-clés

  • Recherche
  • prévention des surdoses d’opioïdes
  • traitement par agonistes opioïdes
  • services de consommation supervisée
  • petites agglomérations
  • santé en milieu rural